Earlier this year we were invited to submit an article to the Medical Writing journal, on the topic of lay summaries in the sphere of generics and biosimilars.
You can read the article here: https://journal.emwa.org/generics-and-biosimilars/layperson-materials-in-the-sphere-of-biosimilars-and-generic-medicines/
Below is the abstract:
Generics and biosimilars offer effective treatment alternatives to branded reference drugs at a lower cost. Despite their widespread use, patients have mis conceptions regarding their efficacy and safety. Layperson materials offer an important means by which patients can be educated in this regard. Here, we provide an overview of generics and biosimilars, describe how layperson materials fit into this landscape from a patientcentricity and regulatory perspective, and provide example language that can be used when developing layperson-orientated materials for generics and biosimilars.